RedChip Companies

Small Stocks, Big Money

Business EN ↓ 146 episodes

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.

Author

RedChip Companies

Category

Business

Podcast website

redchip.com

Latest episode

Jul 7, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

1606 Corp. (OTC: CBDW): Revolutionizing CBD Customer Service with AI Innovation 13.02.2024

1606 Corp. (OTC: CBDW) stands at the forefront of technological innovation in the online CBD industry. With a clear mission to revolutionize customer service in the digital marketplace, 1606 Corp. leverages state-of-the-art artificial intelligence (AI) solutions to address the significant challenges faced by consumers in the online CBD sector. Recognizing the unique needs of each business, 1606 Co...

Mobilicom (NASDAQ: MOB) Israel Ministry of Defense Purchases Mobilicom's Game-Changing Technology! 06.02.2024

Explore a Compelling Investment Opportunity with Mobilicom: Pioneers in the $34 Billion Drone Market! Mobilicom is at the forefront of the drone industry, offering a game-changing investment opportunity. With a unique end-to-end value proposition, they are revolutionizing the way drones operate. Their proprietary solutions are designed to elevate drone performance, provide comprehensive cybersecur...

Meet Shalabh Gupta, CEO of Unicycive Therapeutics (NASDAQ: UNCY) 30.01.2024

We are a biotechnology company dedicated to developing treatments for certain medical conditions. Currently, we have two programs focused on kidney disease that we believe have the potential to offer medical benefit. As we grow the Company and build our team, we intend to focus on identifying medical conditions within and outside of kidney disease. Our current development programs are focused on t...

The INNO (NASDAQ: INHD) Edge: Transforming Construction with Cold-Formed Steel Technology 25.01.2024

INNO Holdings is transforming the construction industry with its innovative approach to sustainable, efficient, and cost-effective building methods. Utilizing advanced steel-framing technology, the Company's solutions reduce construction times by over 50% while significantly cutting labor costs. INNO Holdings manufactures metal studs, prefab wall panels, joists, and trusses offsite, delivering...

INNO Holdings Inc. (NASDAQ: INHD) - Redefining Construction with Steel Tech 09.01.2024

INNO Holdings is transforming the construction industry with its innovative approach to sustainable, efficient, and cost-effective building methods. Utilizing advanced steel-framing technology, the Company's solutions reduce construction times by over 50% while significantly cutting labor costs. INNO Holdings manufactures metal studs, prefab wall panels, joists, and trusses offsite, delivering...

Genetic Technologies Limited (NASDAQ: GENE): Pioneering Genomics for Health and Wellness 02.01.2024

Genetic Technologies Limited (NASDAQ: GENE) is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GTG offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The company has a proprietary risk stratification plat...

bioAffinity Technologies: Exploring the Future of Cancer Care 26.12.2023

bioAffinity Technologies is an emerging player in early-stage cancer diagnosis and treatment. Its flagship product, CyPath® Lung, improves detection of early-stage lung cancer by analyzing the lung microenvironment. The noninvasive test has shown high sensitivity, specificity and accuracy. Lung cancer often goes undetected until it reaches late-stage when treatment options are less effective. Earl...

Meet Maria Zannes: CEO of BioAffinity Technologies (NASDAQ: BIAF) 19.12.2023

bioAffinity Technologies is an emerging player in early-stage cancer diagnosis and treatment. Its flagship product, CyPath® Lung, improves detection of early-stage lung cancer by analyzing the lung microenvironment. The noninvasive test has shown high sensitivity, specificity and accuracy. Lung cancer often goes undetected until it reaches late-stage when treatment options are less effective. Earl...

Innovation in Flight: Mobilicom's End-to-End Solutions for Drone Cybersecurity 05.12.2023

Mobilicom provides cybersecurity and robust solutions for drones and robotics. The Company is positioned to capture market leadership as the top end-to-end provider of hardware and software solutions in the rapidly growing defense and commercial drone and robotics market, a total addressable market expected to reach $8.5 billion by 2026. The Ukraine-Russia conflict is expected to further drive dem...

How Royalty Management Transforms Undervalued Assets 21.11.2023

Royalty Management Holding Corporation identifies and invests in highly undervalued assets in either growing or transitioning marketplaces in order to obtain an ongoing royalty or cashflow stream in the project. RMCO finds undervalued assets that are either under utilized, undeveloped or at an inflection point in their life cycle. Visit RMCOinfo.com to learn more. bit.ly/3FQhAku RedChip Companies,...

Meet Kirk Taylor: CFO of Royalty Management Holding Corporation (NASDAQ: RMCO) 14.11.2023

Royalty Management Holding Corporation (NASDAQ:RMCO) is a royalty company building shareholder value to benefit both our shareholders and communities by acquiring and developing high value assets in a sustainable market environment. Our model is to acquire and structure assets, equity interests, royalty interests and cashflow streams around assets that can support the communities by monetizing the...

Meet Paul Mann: CEO & Chairman of ASP Isotopes 07.11.2023

ASP Isotopes, a leading isotope enrichment company, harnesses cutting-edge technology developed over two decades in South Africa to enrich isotopes of elements and molecules with low atomic masses. Many of these elements are impractical to enrich using conventional methods like centrifuges. ASP Isotopes' primary mission is to produce and market highly enriched isotopes, catering to the healthcare...

Meet Denton Peng: CEO & Chairman of SPI 31.10.2023

Delivering competitive, clean energy solutions to customers for more than 15 years, SPI is an established renewable energy player with global operations in key markets in Asia, Australia, North America, and Europe. SPI has assets of $230 million and currently trades for a fraction of its trailing 12-month revenue of $197 million, a significant discount to peer group multiples. SPI is expected to b...

Meet Simon Morriss: CEO of Genetic Technologies (NASDAQ: GENE) 24.10.2023

Genetic Technologies Limited (Nasdaq: GENE) is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GTG offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The company has a proprietary risk stratification plat...

Meet Jonathan Guarino: CFO of Soligenix (NASDAQ: SNGX) 17.10.2023

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte™ (SGX301 or synthetic hypericin) as a novel photodynamic therapy utilizing safe visible light for the treatment of c...

Meet Dr. Chris Schaber: CEO & President of Soligenix (NASDAQ: SNGX) 10.10.2023

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte™ (SGX301 or synthetic hypericin) as a novel photodynamic therapy utilizing safe visible light for the treatment of c...

Meet Vu Truong, Founder and CEO of Aridis Pharmaceuticals (OTC: ARDS) 03.10.2023

Aridis Pharmaceuticals (OTC: ARDS) is advancing multiple clinical stage monoclonal antibodies (mAbs) targeting bacteria that cause life-threatening infections such as ventilator associated pneumonia (VAP) and hospital acquired pneumonia (HAP), in addition to preclinical stage antiviral mAbs. The use of mAbs as anti-infective treatments represents an innovative therapeutic approach that harnesses t...

Everything Blockchain: Blending Database Security & Blockchain Technologies 25.08.2023

Everything Blockchain (OTC: EBZT) is a key player in building the future where every transaction is trusted and blockchain is used to meet ESG goals, support cities of the future, build and control the transparency of supply chains and ensure the rights of data ownership sustain forever. The Company’s patent-pending advances in blockchain engineering deliver the essential elements needed for real-...

Sharps Technology: Targeting Niche, Multi-Billion-Dollar Markets 24.08.2023

Sharps Technology (NASDAQ: STSS) is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening ne...

Continental Lithium: Addressing the Rapidly Increasing Global Demand for Lithium 23.08.2023

Founded in 2017, Continental Lithium commenced small-scale mining in collaboration with artisanal miners in 2018. Over the last five years, the underlying assets acquired by Continental Lithium have produced approximately 15,000 metric tons of lithium concentrate. The Company has plans to develop its lithium and rare earth mineral assets and substantially increase its production for export to the...

Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity 22.08.2023

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company specializing in developing and commercializing products to treat rare diseases with unmet medical needs. The Company's primary focus is on its Specialized BioTherapeutics business segment, which is responsible for the development of HyBryte™, a novel photodynamic therapy that uses safe visible light for the treatment of cutaneous T...

Graphex Group: Top-10 Global Producer of Graphite Anodes 21.08.2023

Graphex Group (NYSE American: GRFX) is a global leader in the mid-stream deep processing of natural spherical graphite and graphene-related products, key components of the Lithium-ion (Li-ion) batteries used in Electric Vehicles (EVs), renewable energy storage systems, and other use cases. With over a decade of production experience operating at commercial-scale volumes and quality, Graphex is cur...

Meet Shahar Hania, CEO of Rail Vision (NASDAQ:RVSN) 18.08.2023

Rail Vision (NASDAQ: RVSN) is the leading provider of obstacle detection and classification systems in the railway industry. With the Company’s unique cognitive sensor fusion technology, based on advanced electro-optic sensors, artificial intelligence and deep learning, Rail Vision systems detect objects on and along the tracks from a distance of up to two kilometers – in real time – as well as in...

Splash Beverage: Ground-Floor Opportunity with High-Growth Beverage Brands 17.08.2023

Splash Beverage Group (NYSE American: SBEV), an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT flavored tequilas, Pulpoloco sangrías, and TapouT performance hydration and recovery drinks. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire...

Soligenix: A Late-Stage Biopharma Pioneer Tackling Rare Diseases with Unmet Needs 16.08.2023

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte™ (SGX301 or synthetic hypericin) as a novel photodynamic therapy utilizing safe visible light for the treatment of c...

Listen to the Small Stocks, Big Money podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.